Page 8 - Seth Lederman News Today

Results from Planned Interim Analysis Expected First Half 2023 Long COVID Afflicts More Than 30% of Patients Following Infection with SARS-CoV-2, the Virus that

NEW YORK, Aug. 19, 2022 (GLOBE NEWSWIRE) -- FMW Media’s New To The Street / Newsmax TV announces its 377th show line-up, which features the following...

NEW YORK, Aug. 19, 2022 (GLOBE NEWSWIRE) -- FMW Media’s New to The Street TV announces broadcasting its sponsored program business show, airing on...

NEW YORK, Aug. 15, 2022 (GLOBE NEWSWIRE) -- FMW Media’s New to The Street TV announces the broadcasting of its national syndicated show on the Fox...

NEW YORK, Aug. 12, 2022 (GLOBE NEWSWIRE) -- FMW Media's New To The Street / Newsmax TV announces the broadcasting line-up of its national syndicated 1-...

Tonix Pharmaceuticals (NASDAQ:TNXP) CEO Seth Lederman joined Proactives Stephen Gunnion with news that the company has a monkeypox vaccine in development....

Our experience with COVID-19 has shown that you can’t reach herd immunity if you can’t block forward transmission. To interrupt the surge...

01.08.2022 - New patent expected to expire in 2036 Phase 2 Study for Prevention of Migraine Headache Expected to Start Second Half 2022 CHATHAM, N.J., Aug. 01, 2022 (GLOBE NEWSWIRE) - Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage ... Seite 1

Phase 1 Clinical Study Expected to be Initiated in Kenya in the First Half of 2023 World Health Organization Has Declared Monkeypox a Global Health...

CHATHAM, N.J., July 25, 2022 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage...